Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 483

Results: 9
    1
    2
    3
    4
    5

    Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 483, p. N.PAG, doi. 10.1126/scitranslmed.aau2086
    By:
    • Taylor, Mark J.;
    • Ford, Louise;
    • Johnston, Kelly L.;
    • Sjoberg, Hanna T.;
    • Pionnier, Nicolas;
    • Tyrer, Hayley E.;
    • Clare, Rachel H.;
    • Cook, Darren A. N.;
    • Murphy, Emma;
    • Steven, Andrew;
    • Archer, John;
    • Aljayyoussi, Ghaith;
    • Turner, Joseph D.;
    • Ward, Stephen A.;
    • Marsh, Kennan;
    • Carr, Robert;
    • Morton, Howard E.;
    • Kempf, Dale J.;
    • von Geldern, Thomas W.;
    • Hübner, Marc P.
    Publication type:
    Article
    6

    A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 483, p. N.PAG, doi. 10.1126/scitranslmed.aau6267
    By:
    • Verma, Malvika;
    • Langer, Robert;
    • Collins, David;
    • Batra, Shelly;
    • Ahuja, Sandeep;
    • Bajiya, Manju;
    • Batra, Sonali;
    • Sarin, Rohit;
    • Agarwal, Upasna;
    • Khaparde, Sunil D.;
    • Gupta, Neeraj K.;
    • Gupta, Deepak;
    • Vishwanath, Karan;
    • Castaneda, Macy;
    • Salama, John A. F.;
    • Fulop, Daniel J.;
    • Popova, Ellena;
    • Cima, Michael J.;
    • Traverso, Giovanni;
    • Ikeanyi, Chinonyelum
    Publication type:
    Article
    7

    "Inactive" ingredients in oral medications.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 483, p. N.PAG, doi. 10.1126/scitranslmed.aau6753
    By:
    • Reker, Daniel;
    • Steiger, Christoph;
    • Traverso, Giovanni;
    • Blum, Steven M.;
    • Anger, Kevin E.;
    • Sommer, Jamie M.;
    • Fanikos, John
    Publication type:
    Article
    8

    ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 483, p. N.PAG, doi. 10.1126/scitranslmed.aaq1238
    By:
    • Kundu, Samrat T.;
    • Fradette, Jared J.;
    • Byers, Lauren A.;
    • Peng, David H.;
    • Gibbons, Don L.;
    • Diao, Lixia;
    • Tong, Pan;
    • Wang, Jing;
    • Canales, Jaime Rodriguez;
    • Villalobos, Pamela A.;
    • Mino, Barbara;
    • Wistuba, Ignacio I.;
    • Yang, Yanan;
    • Minelli, Rosalba;
    • Peoples, Michael D.;
    • Bristow, Christopher A.;
    • Heffernan, Timothy P.;
    • Carugo, Alessandro
    Publication type:
    Article
    9